CTRI/2026/07/113624进行中（未招募）3 期
A double blind, double dummy, randomized controlled study to evaluate the efficacy of Classical Ayurveda management versus Methotrexate in Rheumatoid Arthritis (AMRA 2.0 ) - AMRA 2.0
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Adults of any gender, aged between 18 and 75 years, meeting
- •2010 ACR or EULAR criteria for Rheumatoid Arthritis
- •2.Anti-CCP or RF positive; if both are negative, a radiograph of
- •hands, wrists and feet (PA and oblique) , clinically conclusive for
- •erosions typical of RA.
- •3.Individuals who are clinically stable
- •for 4 weeks or greater and able to comply to study interventions for
- •4.Individuals who are clinically stable
- •for 4 weeks or greater and able to comply to study interventions for
- •5.History of symptoms
- •of RA for less than 15 years and not wheelchair bound
- •6.Active disease as defined by DAS28 CRP scores greater than or
- •equal to 3.2
排除标准
- •1.History of usage of classical Ayurveda treatment or OTC products for RA for greater
- •than 4 week.
- •2.Currently enrolled in another clinical trial OR received an investigational drug OR has
- •within 3 months (or 5 half-lives, whichever is longer) prior to entry in the study.
研究者
相似试验
进行中（未招募）
3 期
A study to evaluate the efficacy and safety of QVM149 (indacaterol
acetate / glycopyrronium bromide / mometasone furoate) versus salmeterol
xinafoate/fluticasone propionate in children from 12 years to less than 18 years of
age with asthma.RespiratoryPACTR202607586774191Novartis Pharma AG32
招募中
不适用
A Multi-center, single-blind, Randomized Controlled Trial Comparing Interrupted vs Continuous Fascial Closure in the Mini-laparotomy Incision During Laparoscopic or Robot-assisted Colorectal Resection (CLOSURE-CR trial)Colorectal neoplastic lesions including colorectal cancer, appendiceal tumors, neuroendocrine tumorjRCT1030260304900
招募中
4 期
A double blinded, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover, bioequivalence study comparing Lisdexamfetamine Dimesylate capsules 10 mg, manufactured by Ohm Laboratories Inc. (A Sun Pharma Company), 14 Terminal Road, New Brunswick, 08901, NJ, USA with Vyvanse (Lisdexamfetamine Dimesylate) 10 mg capsules; Product of Takeda Canada Inc., Toronto Ontario ON M5H 4E3, Canada, in healthy adult, human subjects under fasting condition.2024-517956-36-00Sun Pharmaceutical Industries Limited64
招募中
4 期
A double blinded, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine Delayed Release Tablets USP 1.2 g manufactured by Sun Pharmaceutical Industries Limited, India with Mezavant (mesalamine) Delayed and Extended-Release Tablets 1.2 g product of Takeda Canada Inc., in healthy, adult, human subjects under fed condition.ulcerative colitis2025-521598-16-00Sun Pharmaceutical Industries Limited168
进行中（未招募）
Unknown
Randomized Controlled, Double-Blind, Double-Simulated Study on Qianlie Tongluo Decoction in the Treatment of Type III Chronic Nonbacterial Prostatitis with Damp-Heat Stasis SyndromeType III ProstatitisGA91.0ITMCTR2026001714Dongzhimen Hospital, Beijing University of Chinese Medicine